Volume 148, Issue 7, Pages (June 2015)

Slides:



Advertisements
Similar presentations
Cell Signaling Lecture 13 and 14. Ligand-activated Notch undergoes 2 cleavages before releasing the transcription factor ADAM10: A disintegrin and Metalloprote.
Advertisements

Nithya Krishnamurthy, Razelle Kurzrock  Cancer Treatment Reviews 
The Wnt signaling pathway in cancer
Reconstitution of Normal Hepcidin Expression in Hfe-Deficient Mice After Liver Transplantation: A New Role of HFE in Kupffer Cells?  Ivana De Domenico,
Volume 59, Issue 5, Pages (November 2013)
Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
Cellular and Molecular Mechanisms of Liver Injury
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
David Largaespada, Nancy Ratner  Cancer Cell 
Lipids in Liver Disease: Looking Beyond Steatosis
Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
The Chromosomal Instability Pathway in Colon Cancer
Volume 47, Issue 1, Pages (July 2007)
Cellular and Molecular Mechanisms of Liver Injury
Hedgehog signaling in the liver
Volume 142, Issue 6, Pages (May 2012)
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
Jan-Hendrik B. Hardenberg, Andrea Braun, Michael P. Schön 
Victoria Sherwood, Irene M. Leigh  Journal of Investigative Dermatology 
Is Hepatitis C Virus Carcinogenic?
Notch: Filling a Hole in T Helper 2 Cell Differentiation
Hematopoietic stem cell fate decisions are regulated by Wnt antagonists: Comparisons and current controversies  Corey J. Cain, Jennifer O. Manilay  Experimental.
Nat. Rev. Endocrinol. doi: /nrendo
In the Zone: How a Hepatocyte Knows Where It Is
Figure 5 Drugs that target WNT signalling
Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Nephrol. doi: /nrneph
Volume 66, Issue 2, Pages (February 2017)
Caught in the Akt: Regulation of Wnt Signaling in the Intestine
Wnt/β-Catenin Signaling: Turning the Switch
Figure 1 WNT signalling pathways
Peter J. Nelson, Thomas O. Daniel  Kidney International 
P-Cadherin Regulates Human Hair Growth and Cycling via Canonical Wnt Signaling and Transforming Growth Factor-β2  Liat Samuelov, Eli Sprecher, Daisuke.
Mark S. Nanes, M.D., Ph.D., Caleb B. Kallen, M.D., Ph.D. 
Volume 59, Issue 5, Pages (November 2013)
Plant Hormones and Signaling: Common Themes and New Developments
The Role of Smads in Skin Development
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
The Primary Cilium as a Complex Signaling Center
Dongwon Kim, Luis A. Garza  Journal of Investigative Dermatology 
The Ying and Yang of Bacterial Signaling in Necrotizing Enterocolitis
Volume 119, Issue 3, Pages (September 2000)
Tyrosine Phosphorylation of Human Keratinocyte β-Catenin and Plakoglobin Reversibly Regulates their Binding to E-Cadherin and α-Catenin  Peiqi Hu, Edward.
Met as a therapeutic target in HCC: Facts and hopes
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Long Noncoding RNA in Hematopoiesis and Immunity
Shifted from Wnt to Hedgehog Signaling Pathways
p38δ and PKD1: Kinase Switches for Insulin Secretion
Volume 123, Issue 6, Pages (December 2002)
A Versatile Transcriptional Effector of Wingless Signaling
Lipids in Liver Disease: Looking Beyond Steatosis
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Wnt/β-Catenin Signaling in Development and Disease
The Expanding Cosmos of Nuclear Receptor Coactivators
Long Noncoding RNAs and Hepatocellular Carcinoma
Polycystic kidney disease: Cell division without a c(l)ue?
A Wnt Survival Guide: From Flies to Human Disease
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
GPC5 Gene and Its Related Pathways in Lung Cancer
Volume 131, Issue 5, Pages (November 2006)
The Salt-Inducible Kinases: Emerging Metabolic Regulators
EpCAM in hepatocytes and their progenitors
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Volume 119, Issue 4, Pages (October 2000)
Nat. Rev. Rheumatol. doi: /nrrheum
Volume 4, Issue 4, Pages (April 2009)
The Forkhead Transcription Factor Foxo1
Nat. Rev. Urol. doi: /nrurol
Making Cancer Quiescent: SPDEF De-Cycles Beta-Catenin
Reconstitution of Normal Hepcidin Expression in Hfe-Deficient Mice After Liver Transplantation: A New Role of HFE in Kupffer Cells?  Ivana De Domenico,
Presentation transcript:

Volume 148, Issue 7, Pages 1294-1310 (June 2015) β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis  Satdarshan Pal Monga  Gastroenterology  Volume 148, Issue 7, Pages 1294-1310 (June 2015) DOI: 10.1053/j.gastro.2015.02.056 Copyright © 2015 Terms and Conditions

Figure 1 WNT Signaling via β-catenin. (A) In the absence of WNT or in the presence of WNT inhibitors, β-catenin is phosphorylated at specific serine and threonine residues in exon 3 by kinases in the degradation complex, leading to recognition by β-transducin repeat-containing protein for destruction. Mutations affecting these residues can lead to stabilization of the β-catenin protein. (B) WNT protein is palmitoylated and glycosylated by porcupine (Porcup) in the endoplasmic reticulum and transported by wntless (WLS) protein from the Golgi apparatus to the membrane for secretion. Secreted WNT binds to its receptor (FZ) and co-receptors LRP5 or LRP6. The signal is transduced through disheveled to inactivate the β-catenin degradation complex, leading to nuclear translocation of β-catenin. In the nucleus, β-catenin interacts with LEF/TCF transcription factors to regulate the expression of target genes. (C) WNT5A either can activate or inhibit β-catenin signaling, depending on the type of FZD expressed by a cell. WNT5A can activate β-catenin signaling in the presence of frizzled-4 (FZD4), although it inhibited β-catenin in the presence of FZD2 or an alternate WNT receptor called the receptor tyrosine kinase-like orphan receptor 2. β-cat, β-catenin; CK, casein kinase; Dsh, disheveled; P, phosphorylation; WIF, WNT inhibitory factor. Gastroenterology 2015 148, 1294-1310DOI: (10.1053/j.gastro.2015.02.056) Copyright © 2015 Terms and Conditions

Figure 2 β-catenin structure and role in adherens junctions. (A) Specific amino acids in β-catenin regulate its stability, activity, and interactions with other proteins. (B) In a normal liver, β-catenin acts as a bridge between the intracytoplasmic tail of E-cadherin and the actin cytoskeleton to regulate cell adhesion. Molecules such as HGF, EGF, FER kinase, and SRC can affect this complex negatively through tyrosine phosphorylation of β-catenin at specific residues. The end result of dissociation of the complex in some cases can result in nuclear translocation and activation of β-catenin. Left: in the absence of β-catenin, γ-catenin is able to maintain AJs by binding to E-cadherin and actin cytoskeleton. γ-Catenin did not compensate for nuclear β-catenin function. EGF, epidermal growth factor; JAM-A, junctional adhesion molecule-A; jxns, junctions. Gastroenterology 2015 148, 1294-1310DOI: (10.1053/j.gastro.2015.02.056) Copyright © 2015 Terms and Conditions

Figure 3 Interactions among β-catenin, HNF4α, and TCF4 in periportal and pericentral hepatocytes. (Left panel) β-catenin binds to TCF4 and this complex binds to WNT response elements in promoters of target genes in pericentral hepatocytes. Here, TCF can bind to the HNF4α response elements, making it unavailable for HNF4α to bind and transactivate its target genes. Furthermore, β-catenin can bind HNF4α to prevent its binding to gene promoters. β-catenin signaling via TCF4 therefore is activated and HNF4α transactivation is inactivated in these cells. (Right panel) In periportal hepatocytes, HNF4α binds to HNF4α response elements in promoters of target genes to induce their expression while also occupying WNT response elements, preventing TCF binding. Furthermore, HNF4α can bind β-catenin and TCF to keep them engaged and prevent binding to target gene promoters. HNF4α signaling therefore is activated and β-catenin signaling via TCF4 is inactivated in these cells. β-cat, β-catenin. Gastroenterology 2015 148, 1294-1310DOI: (10.1053/j.gastro.2015.02.056) Copyright © 2015 Terms and Conditions

Figure 4 WNT signaling to β-catenin during adipogenesis and activation of hepatic stellate cells. Inhibition of WNT signaling to β-catenin is required for differentiation of preadipocytes into adipocytes, regulating expression of genes that control adipogenesis such as PPARγ and CCAAT enhancer binding protein-α (CEBPα). HSC differentiation into active myofibroblasts is analogous to de-differentiation of adipocytes to preadipocytes (losing adipogenic properties). WNT activation of β-catenin promotes this process by negatively regulating the expression of PPARα and CEBPα. WNT signaling via β-catenin therefore might be inhibited to treat patients with fibrosis: it would activate the expression of genes involved in adipogenesis-induced quiescence of activated stellate cells. Gastroenterology 2015 148, 1294-1310DOI: (10.1053/j.gastro.2015.02.056) Copyright © 2015 Terms and Conditions